Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Papillomavirus Infections 1 Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma in Situ 1

Interventions

pembrolizumab 38 Bevacizumab 23 Cyclophosphamide 22 Standard of Care 18 Blood Specimen Collection 17 Carboplatin 16 Paclitaxel 15 Nivolumab 14 Gemcitabine 14 Pemetrexed 13 Exercise 13 Cisplatin 12 atezolizumab 11 Radiotherapy 11 Fluorouracil 11 Doxorubicin 11 Surveys and Questionnaires 9 Rituximab 9 Oxaliplatin 9 Magnetic Resonance Spectroscopy 9 Leucovorin 9 Cetuximab 9 Biopsy 9 130-nm albumin-bound paclitaxel 9 durvalumab 8 abemaciclib 8 Docetaxel 8 olaparib 7 Temozolomide 7 Prednisone 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Cell Count × 90 days × Clear all

NCT05887882 2026-04-24

PNOC028

University of California, San Francisco

Phase 1 Suspended

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡